Monteverde & Associates Launches Inquiry into Aethlon Medical Merger

Shareholders of Aethlon Medical, Inc. are facing scrutiny over a proposed merger with North Immunology, Inc., as New York-based law firm Monteverde & Associates PC initiates an investigation into the transaction. The deal currently leaves Aethlon investors with approximately 4.75% ownership of the resulting combined company.

Today, 21:15· Money Talk· 231 reads

Monteverde & Associates Launches Inquiry into Aethlon Medical Merger

The investigation centers on whether the terms of the merger provide fair value to existing Aethlon shareholders. Juan Monteverde, whose firm is recognized in the 2025 ISS Securities Class Action Services Report, is spearheading the inquiry from their offices in the Empire State Building.

Investors holding common stock in the medical technology company are encouraged to review the terms of the agreement. The firm is offering free consultations to evaluate whether the deal adequately protects shareholder interests. Those seeking further information or wishing to discuss potential concerns regarding the transition can contact Monteverde & Associates directly via their website, by email, or by calling their New York office at (212) 971-1341.

Monteverde & Associates Launches Inquiry into Aethlon Medical Merger

Comments (0)